)

Lyell Immunopharma (LYEL) investor relations material
Lyell Immunopharma H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key program updates and clinical progress
Lead program is a dual-targeting CD19/20 CAR T cell therapy, now named RondaCell, for relapsed/refractory large B-cell lymphoma.
Pivotal single-arm study underway for third-line approval; phase 3 randomized head-to-head trial launching in second line.
RondaCell showed 88% overall response and 70% complete response rates in third-line patients.
Six-month complete response rate reached 71%, surpassing benchmarks set by current CD19 CARs.
Broader patient inclusion in trials, including older and high-risk populations.
Competitive landscape and differentiation
Dual-targeting CD19/20 CARs are outperforming single-target CD19 CARs in response rates and durability.
RondaCell uses a single tandem CAR with full potency for both antigens and a 4-1BB domain, linked to lower neurotoxicity.
Unique enrichment for naïve central memory T cells, associated with better outcomes and persistence.
Lower rates of CRS and neurotoxicity compared to competitors; proactive safety measures implemented.
Confident in leadership position, being first to two pivotal trials and a head-to-head study.
Market strategy and commercialization plans
Third-line setting seen as both a commercial opportunity and a regulatory bridge to second line.
Strategic selection of clinical trial sites to facilitate rapid commercial adoption.
Manufacturing capacity supports up to 1,200 doses per year, enabling independent launch.
Open to future partnerships, especially for ex-U.S. markets, but no urgency due to current resources.
Expectation that CD19/20 CARs will disrupt and potentially replace current CD19 therapies.
Next Lyell Immunopharma earnings date

Next Lyell Immunopharma earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage